Radiation-Induced Esophagitis Exacerbated by Everolimus

BACKGROUND: Everolimus, a potent mammalian target of rapamycin (mTOR) inhibitor, has shown anticancer activity against various types of cancer, including renal cell carcinoma (RCC); however, little information is available on the efficacy and safety of the combination of everolimus and radiotherapy....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Miura, Yuji, Suyama, Koichi, Shimomura, Akihiko, Miyakawa, Jimpei, Kobayashi, Hiroki, Uki, Akiyoshi, Okaneya, Toshikazu, Takano, Toshimi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2013
Aiheet:
Published online: June, 2013
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3725027/
https://ncbi.nlm.nih.gov/pubmed/23898276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000353309
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia